Curis Lifesciences Limited (CURIS)
Curis Lifesciences announces the resignation of Independent Director Ms. Dhruvi Shyam Kapadia, effective April 1, 2026. The resignation is due to her pre-occupancy and increased professional commitments, with no other material reasons cited.
Mar 31 2026 18:03:00
Curis Lifesciences Limited (CURIS)
Dhruvi Kapadia has resigned as an Independent Director of Curis Lifesciences, effective April 1, 2026. The resignation is attributed to pre-occupancy and increased professional commitments, with the company initiating necessary regulatory filings.
Mar 31 2026 18:03:00
Curis Lifesciences Limited (CURIS)
Curis Lifesciences announced the resignation of Independent Director Dhruvi Shyam Kapadia, effective April 1, 2026. Her resignation is attributed to pre-occupancy and increased professional commitments, with no other material reasons cited.
Mar 31 2026 18:03:00
Curis Lifesciences Limited (CURIS)
Curis Lifesciences board approved acquiring a 51% stake in Uninova Lifesciences for ₹20.65 lakh cash, making it a subsidiary. This expands the company's presence in the pharmaceutical industry. The acquisition is expected to be completed within 30 days.
Mar 30 2026 17:03:00
Curis Lifesciences Limited (CURIS)
Curis Lifesciences board approved acquiring a 51% stake in Uninova Lifesciences for ₹20.65 lakh cash, making it a subsidiary. This expands the company's presence in the pharmaceutical industry. The acquisition is expected to be completed within 30 days.
Mar 30 2026 17:03:00
Curis Lifesciences Limited (CURIS)
Curis Lifesciences appointed NGST & Associates as its internal auditor and Sachin Thakkar & Associates as its secretarial auditor, both for a 1-year term. These appointments are effective March 28, 2026, strengthening the company's audit and compliance functions.
Mar 30 2026 16:03:00
Curis Lifesciences Limited (CURIS)
Curis Lifesciences board approved acquiring a 51% stake in Uninova Lifesciences for ₹20.65 lakh cash, making it a subsidiary. This expands the company's presence in the pharmaceutical industry. The acquisition is expected to be completed within 30 days.
Mar 30 2026 16:03:00
Curis Lifesciences Limited (CURIS)
Curis Lifesciences agreed to a strategic investment in Uninova Lifesciences Private Limited, acquiring a 51% equity stake for ₹20.65 lakhs. This move aims to expand its business and diversify its market presence in the pharmaceutical industry.
Mar 30 2026 15:03:00
Curis Lifesciences Limited (CURIS)
Curis Lifesciences agreed to a strategic investment in Uninova Lifesciences Private Limited, acquiring a 51% equity stake for ₹20.65 lakhs. This move aims to expand its business and diversify its market presence in the pharmaceutical industry.
Mar 30 2026 15:03:00
Read More